4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001957554-26-000005
Chief Financial Officer gave up 4,984 shares (to pay taxes)
- Chief Financial Officer acquired 14,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Balthaser Kevin · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-01 | Exercise or conversion : show line 1 in the form | +14,750 | 175,163 | D | ||
| 2026-02-01 | Shares withheld for taxes : show line 2 in the form | −4,984 | $3.51 | $17,494 | 170,179 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −14,750 | 29,500 | D |
Loading xslF345X05/form4-02032026_100245.xml…